Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BDKRB1 Antikörper (Cys250Ser-Mutant)

KO Validated BDKRB1 Reaktivität: Ratte WB, IF, IHC, IC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7042967
  • Target Alle BDKRB1 Antikörper anzeigen
    BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
    Bindungsspezifität
    • 16
    • 7
    • 6
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 243-257, Cys250Ser-Mutant
    Reaktivität
    • 54
    • 23
    • 21
    • 4
    • 1
    • 1
    Ratte
    Wirt
    • 52
    • 3
    • 1
    Kaninchen
    Klonalität
    • 55
    • 1
    Polyklonal
    Konjugat
    • 29
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BDKRB1 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 19
    • 17
    • 14
    • 13
    • 12
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunochromatography (IC)
    Verwendungszweck
    A Rabbit Polyclonal Antibody to B1 Bradykinin Receptor
    Spezifität
    3rd intracellular loop
    Kreuzreaktivität
    Maus, Ratte
    Kreuzreaktivität (Details)
    Might not recognize the human epitope.
    Homologie
    Mouse - 13,15 amino acid residues identical
    Produktmerkmale
    Anti-B1 Bradykinin Receptor (BDKRB1) Antibody (ABIN7042967, ABIN7043940 and ABIN7043941)) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot, immunohistochemistry, and immunocytochemistry applications. It has been designed to recognize B1R from rat and mouse samples. The antibody may not recognize the receptor from human samples.
    Aufreinigung
    Affinity purified on immobilized antigen.
    Güteklasse
    KO Validated
    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)KEAS RTR*SG GPKGS K, corresponding to amino acid residues 243-257 of rat B1R with replacement of cysteine 250 (C250) with serine (*S)

    Isotyp
    IgG
    Top Product
    Discover our top product BDKRB1 Primärantikörper
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:50

    Application Dilutions Western blot wb: 1:200

    Kommentare

    Cited Application: IHC

    Negative Control: BLP-BR011

    Blocking Peptide: BLP-BR011

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    0.2 mL double distilled water (DDW).
    Konzentration
    1 mg/mL
    Buffer
    PBS pH 7.4
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target
    BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
    Andere Bezeichnung
    BDKRB1 (BDKRB1 Produkte)
    Hintergrund
    B1R, BKR1, B1BKR, BKRB1, Kinin B1, BRADYB1,Kinins are small peptides rapidly produced following tissue injury that serve as important modulators of inflammation and pain. In the periphery, the actions of kinins include vasodilatation, increased vascular permeability, stimulation of immune cells, and induction of pain. Kinins in the central nervous system (CNS) appear to initiate a similar cascade of events leading to neural tissue damage as well as long lasting disturbances affecting blood-brain barrier function.1Kinins such as Bradykinin (BK), Lys-BK, desArg9-BK, and Lys-desArg9-BK exert their action via two distinct receptors: the B1 Bradykinin receptor (BKRB1) and the B2 Bradykinin receptor (BKRB2). The desArg9-BK and Lys-desArg9-BK peptides activate BKRB1 while BK and Lys-BK operate by activating BKRB2.2 Both BKRB1 and BKRB2 are members of the seven-transmembrane domain, G protein-coupled receptor (GPCR) superfamily and share a common structure of seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxyl terminus.Expression of BKRB1is inducible upon various types of tissue injury and by inflammatory mediators such as bacterial lipopolysaccharide (LPS) and cytokines. BKRB1 was long considered not to be expressed in healthy tissues. However, recent work has demonstrated a low level of expression of BKRB1 in the CNS of rodent and primates. In contrast, BKRB2 is constitutively expressed on various cell types.3 BKRB1 represents a potential therapeutic target for treatment of inflammatory disorders and cardiovascular diseases.

    Alternative names: B1 Bradykinin Receptor (BDKRB1), B1R, BKR1, B1BKR, BKRB1, Kinin B1, BRADYB1
    Gen-ID
    81509
    NCBI Accession
    NM_000710
    UniProt
    P97583
    Pathways
    ACE Inhibitor Pathway
Sie sind hier:
Kundenservice